ReviewClinical Medicine Insights. Oncology2021

Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development.

Ke Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.